Three-Year Glycaemic Control and Management in Patients with Type 2 Diabetes Initiating Second-Line Treatment in Japan: A Prospective Observational Study, J-DISCOVER

被引：0
|
作者：
Mitsuyoshi Takahara
Tomoya Mita
Naoto Katakami
Fumitaka Wada
Naru Morita
Yoko Kidani
Toshitaka Yajima
Iichiro Shimomura
Hirotaka Watada
机构：
[1] Osaka University,Department of Diabetes Care Medicine, Graduate School of Medicine
[2] Juntendo University Graduate School of Medicine,Department of Metabolism and Endocrinology
[3] Osaka University,Department of Metabolic Medicine, Graduate School of Medicine
[4] AstraZeneca K.K.,Medical Affairs
来源：
Diabetes Therapy | 2022年 / 13卷
关键词：
Antidiabetic drugs; Diabetes complications; Glycaemic control; Second-line treatment; Type 2 diabetes mellitus;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：251 / 264
页数：13
相关论文
共 50 条
  • [21] Rationale and Design for the J-DISCOVER Study: DISCOVERing the Treatment Reality of Type 2 Diabetes in a Real-World Setting in Japan-A Protocol
    Katakami, Naoto
    Mita, Tomoya
    Takahara, Mitsuyoshi
    Hashigami, Kiyoshi
    Kawashima, Masaru
    Shimomura, Iichiro
    Watada, Hirotaka
    DIABETES THERAPY, 2018, 9 (01) : 165 - 175
  • [22] Treatment patterns and associated factors in 14 668 people with type 2 diabetes initiating a second-line therapy: Results from the global DISCOVER study programme
    Nicolucci, Antonio
    Charbonnel, Bernard
    Gomes, Marilia B.
    Khunti, Kamlesh
    Kosiborod, Mikhail
    Shestakova, Marina V.
    Shimomura, Iichiro
    Watada, Hirotaka
    Chen, Hungta
    Cid-Razufa, Javier
    Fenici, Peter
    Hammar, Niklas
    Surmont, Filip
    Tang, Fengming
    Pocock, Stuart
    DIABETES OBESITY & METABOLISM, 2019, 21 (11): : 2474 - 2485
  • [23] Glycaemic, lipid and blood pressure control according to guidelines in patients initiating second-line glucose-lowering therapy: results from the global DISCOVER study
    Gomes, M. B.
    Charbonnel, B.
    Cid-Ruzafa, J.
    Fenici, P.
    Hammar, N.
    Khunti, K.
    Kosiborod, M.
    Nicolucci, A.
    Pocock, S.
    Shestakova, M. V.
    Watada, H.
    Shimomura, I.
    Tang, F.
    Ji, L.
    DIABETOLOGIA, 2017, 60 : S140 - S140
  • [24] Changes in HbA1c and treatment in the second year following initiation of second-line therapy in people with type 2 diabetes: the global DISCOVER study
    Nicolucci, A.
    Chen, H.
    Fenici, P.
    Gomes, M. B.
    Saraiva, G. Luporini
    Medina, J.
    Pocock, S.
    Shestakova, M. V.
    Shimomura, I.
    Surmont, F.
    Tang, F.
    Vora, J.
    Watada, H.
    Khunti, K.
    Charbonnel, B.
    DIABETOLOGIA, 2019, 62 : S176 - S177
  • [25] Individualized HbA1c Targets in People with Type 2 Diabetes Initiating Second-Line Therapy-The Global DISCOVER Study
    Khunti, Kamlesh
    Chen, Hungta
    Cid-Ruzafa, Javier
    Fenici, Peter
    Gomes, Marilia B.
    Hammar, Niklas
    Kennedy, Kevin
    Kosiborod, Mikhail
    Pocock, Stuart
    Shestakova, Marina V.
    Shimomura, Iichiro
    Surmont, Filip
    Ji, Linong
    DIABETES, 2018, 67
  • [26] What are the factors associated with long-term glycaemic control in patients with type 2 diabetes and elevated glycated haemoglobin (≥7.0%) at initiation of second-line therapy? Results from the DISCOVER study
    Bonnet, Fabrice
    Chen, Hungta
    Cooper, Andrew
    Gomes, Marilia B.
    Ji, Linong
    Leigh, Paul
    Ramirez, Larisa
    Shestakova, Marina, V
    Shimomura, Iichiro
    Siddiqui, Afrah
    Tang, Fengming
    Vora, Jiten
    Watada, Hirotaka
    Khunti, Kamlesh
    DIABETES OBESITY & METABOLISM, 2021, 23 (10): : 2336 - 2343
  • [27] THE EFFECT OF A THREE YEAR EXERCISE INTERVENTION ON GLYCAEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETES
    Hordern, M.
    Prins, J.
    Marwick, T.
    Coombes, J.
    INTERNAL MEDICINE JOURNAL, 2015, 45 : 11 - 12
  • [28] Treatment patterns and glycated haemoglobin levels over 36 months in individuals with type 2 diabetes initiating second-line glucose-lowering therapy: The global DISCOVER study
    Charbonnel, Bernard H.
    Chen, Hungta
    Cid-Ruzafa, Javier
    Cooper, Andrew
    Fenici, Peter
    Gomes, Marilia B.
    Saraiva, Gabriela L.
    Medina, Jesus
    Nicolucci, Antonio
    Shestakova, Marina, V
    Shimomura, Iichiro
    Surmont, Filip
    Tang, Fengming
    Vora, Jiten
    Watada, Hirotaka
    Khunti, Kamlesh
    DIABETES OBESITY & METABOLISM, 2023, 25 (01): : 46 - 55
  • [29] Patterns of glycaemic control in patients with type 2 diabetes mellitus initiating second-line therapy after metformin monotherapy: Retrospective data for 10256 individuals from the United Kingdom and Germany
    Khunti, Kamlesh
    Godec, Thomas R.
    Medina, Jesus
    Garcia-Alvarez, Laura
    Hiller, Josh
    Gomes, Marilia B.
    Cid-Ruzafa, Javier
    Charbonnel, Bernard
    Fenici, Peter
    Hammar, Niklas
    Hashigami, Kiyoshi
    Kosiborod, Mikhail
    Nicolucci, Antonio
    Shestakova, Marina V.
    Ji, Linong
    Pocock, Stuart
    DIABETES OBESITY & METABOLISM, 2018, 20 (02): : 389 - 399
  • [30] Treatment patterns for first- and second-line management of type 2 diabetes in the Middle East and North Africa region: insights from DISCOVER
    Al-Rubeaan, K.
    Echtay, A.
    Bayram, F.
    Malek, R.
    Kok, A.
    Bennakhi, A.
    Hafidh, K.
    Roushdy, E.
    Rajadhyaksha, V.
    Alsayed, M.
    DIABETOLOGIA, 2021, 64 (SUPPL 1) : 154 - 155
12345